R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Location Date Req ID Sort ascending
Reset
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 6 Feb 2026 351
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases UK, GB 14 Feb 2026 5448
Clinical Program Leader
Clinical Program Leader Europe - Remote, IT 2 Feb 2026 5902
Europe - Remote, IT 2 Feb 2026 5902
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 29 Jan 2026 5993
PARMA, IT 29 Jan 2026 5993
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 16 Feb 2026 6111
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 22 Jan 2026 6204
United States, US 22 Jan 2026 6204
Sr. Director, Clinical Programs, Global Rare Diseases Boston, MA, US 24 Jan 2026 6205
Senior Director, Clinical Biometrics & Analytics Parma, IT 12 Feb 2026 6387
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026 Cary, NC, US 14 Feb 2026 6413
Clinical Trial Documentation & Records Management Lead Parma, IT 15 Feb 2026 6428
R&D Manufacturing & Technology Transfer Manager Parma, IT 20 Jan 2026 6501
Senior Global Project Manager
Senior Global Project Manager Italy, IT 30 Jan 2026 6546
Italy, IT 30 Jan 2026 6546
Senior Global Project Manager
Senior Global Project Manager Cary, USA, US 5 Feb 2026 6561
Cary, USA, US 5 Feb 2026 6561
Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 10 Feb 2026 6592
Clinical Operations Intern
Clinical Operations Intern Toronto, CA 12 Feb 2026 6934
Toronto, CA 12 Feb 2026 6934